peptides

  • EBV (EBNA-LP)

    EBV (EBNA-LP)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear…

  • EBV (EBNA1)

    EBV (EBNA1)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear…

  • EBV (EBNA3a)

    EBV (EBNA3a)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear…

  • EBV (EBNA3b)

    EBV (EBNA3b)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear…

  • EBV (EBNA3c)

    EBV (EBNA3c)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear…

  • EBV (Envelope glycoprotein H)

    EBV (Envelope glycoprotein H)

    Amount: 25 ??g (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Envelope protein Purity: Development Grade: each…

  • EBV (GP350/GP340)

    EBV (GP350/GP340)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Envelope protein…

  • EBV (HHV4) Latent membrane protein 2 419-427, TYGPVFMSL

    EBV (HHV4) Latent membrane protein 2 419-427, TYGPVFMSL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-TYGPVFMSL-OH Specifications: 9mer peptide as TFA salt

  • EBV (LMP1)

    EBV (LMP1)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane…

  • EBV (LMP2)

    EBV (LMP2)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infection, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in glass vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane…

  • EBV Apoptosis regulator BHRF1  122-133, PYYVVDLSVRGM

    EBV Apoptosis regulator BHRF1 122-133, PYYVVDLSVRGM

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Apoptosis regulator BHRF1 Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-PYYVVDLSVRGM-OH Specifications: 12mer peptide as TFA salt

  • EBV BMLF1 280-288 Peptide (HLA-A*02:01) - GLCTLVAML

    EBV BMLF1 280-288 Peptide (HLA-A*02:01) – GLCTLVAML

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: BMLF1 (mRNA export factor EB2) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-GLCTLVAML-OH Specifications: 9mer peptide as TFA salt

  • EBV BZLF1 169-181 Peptide (HLA-B*18:01) - EECDSELEIKRY

    EBV BZLF1 169-181 Peptide (HLA-B*18:01) – EECDSELEIKRY

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: BZLF1 Trans-activator protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-EECDSELEIKRY-OH

  • EBV BZLF1 190-197 Peptide (HLA-B*08:01) - RAKFKQLL

    EBV BZLF1 190-197 Peptide (HLA-B*08:01) – RAKFKQLL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: BZLF1 Trans-activator protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RAKFKQLL-OH Specifications: 8mer peptide as TFA salt

  • EBV BZLF1 209-217 Peptide (HLA-B*40:02) - SENDRLRLL

    EBV BZLF1 209-217 Peptide (HLA-B*40:02) – SENDRLRLL

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: BZLF1 Trans-activator protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SENDRLRLL-OH

  • EBV BZLF1 54-64 Peptide (HLA-B*35:01) - EPLPQGQLTAY

    EBV BZLF1 54-64 Peptide (HLA-B*35:01) – EPLPQGQLTAY

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: BZLF1 Trans-activator protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-EPLPQGQLTAY-OH Specifications: 11mer peptide as TFA salt